Organs (liver, kidney, spleen, lung, heart, brain and muscle) and extracted tumour biodistribution (Figure 3C) assessed by ex-vivo organ imaging 24 h after injection confirmed the selective brain tumour targeting of anti-IGFBP7 sdAb, but not NC sdAb. The gene discussed is IGFBP7; the disease is neoplasm.